ServiceUpdated on 20 August 2025
Aseptic Fill and Finishing of small and large molecules for early phase development and small volume drug products
About
Accelerate your clinical drug delivery with phase appropriate aseptic fill‑finish
PHOENIX SEP services covers filling&finishing capabilities for advanced nanotechnology-based medicinal products.
We offer bubble‑free filling in vials of 2 R and 10 R including 100% visual inspection.
Our batch capacity is flexible and Ideal for small‑ to mid‑scale clinical supply up to 1,000 vials per batch — bridging early development to GMP readiness.
We operate a dynamic unidirectional laminar flow biological safety cabinet (Class A) in Class B environment, minimizing contamination risks.
Our experiences include ICH-compliant stability studies under storage conditions from –80 °C through ambient and GMP‑compliant labelling, release, and shipment.
Why choose us:
Purpose‑built aseptic tech tailored for clinical trial material (IMP), aligning with EU-Annex 1 and global regulatory standards.
Dedicated workflows optimized for both small‑ and large‑molecule therapeutics.
Seamless integration of formulation, fill‑finish, QC testing, and shipment — all under GMP.
Type
- Development
- Manufacturing
Applies to
- Biotech and Lifescience
Organisation
Similar opportunities
Service
PHOENIX SEP: Your Single Entry Point for Nanopharmaceutical Development
- Others
- Medtech
- Consulting
- Development
- Manufacturing
- Microtechnology
- Biotech and Lifescience
Expertise
Single Entry Point (SEP) for Nano-pharmaceutical Innovative Products
- Biotech, Pharma and Cosmetics